This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 203 Users Online

Anti-biofilm Wound Dressing Market

Global Market Study on Anti-biofilm Wound Dressing: Surge in injury occurrences and burn accidents to Accelerate the Market Growth

Anti-biofilm Wound Dressing Market by Mode of Mechanism - Physical (Manual Debridement, Pulse Electrical Field, Ultrasound Debridement), Chemical (Ionic, Silver, Iodine, EDTA), and Biological (Dispersin B, Lactoferrin, Bacteriophage)

Global Anti-biofilm Wound Dressing Market Outlook

Newly-released Anti-biofilm Wound Dressing industry analysis report by Persistence Market Research shows that the global revenue of the Anti-biofilm Wound Dressing Market in 2022 was held at US$ 729.7 Million. With a CAGR of 11.2% from 2023 to 2033, the market is projected to reach a US$ 2.3 billion valuation by 2033. The Chemical Mode of Mechanism is expected to be the highest revenue-generating segment, accounting for a CAGR of nearly 10.6% during 2023 – 2033.

Attribute

Details

Global Anti-biofilm Wound Dressing Market (2023)

US$ 807 Million

Global Anti-biofilm Wound Dressing Market (2033)

US$ 2.3 Billion

Global Anti-biofilm Wound Dressing Market CAGR (2023 to 2033)

11.2%

U.S. Anti-biofilm Wound Dressing Market CAGR (2023 to 2033)

11.8%

Key Companies Profiled

  • ConvaTec
  • Smith & Nephew PLC
  • Urgo Medical
  • Coloplast
  • 3M
  • Urgo Medical
  • Next Science
  • Monarch Labs
  • Mega Pharma (Pvt) Ltd.
  • BioMonde
  • B. Braun Melsungen AG
  • Molnlycke Healthcare
  • Lohmann & Rauscher
  • Arobella Medical
Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Revenue of Anti-biofilm Wound Dressing from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033

As per the Anti-biofilm Wound Dressing industry research by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the Anti-biofilm Wound Dressing industry increased at around 10% CAGR, wherein, countries such as the U.S., U.K., China, Japan, and South Korea held a significant share in the global market.

Growth in injury occurrences, vehicular mishaps, and burn accidents is predicted to drive the international road-safety market. For example, the Association for Safe International Road Travel estimates that roughly 1.35 million people die every year in a road accident, while on average, 3,700 people are reported dead on roads every day. Owing to this, the Anti-biofilm Wound Dressing Market is projected to grow at a CAGR of 11.2% over the coming 10 years.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

What are the challenges associated with Anti-biofilm Wound Dressing Market?

Treating acute and chronic infected wounds with resident biofilm remains a big issue in medical care, according to Frontiers Media S.A. research. Antimicrobial dressing interactions with bacterial load, biofilm matrix, and the overall protein-rich wound milieu are also poorly understood. As a result, the goal of this work is to use an in-vitro biofilm model that mimics the particular biofilm environment in human wounds to expand the investigation into the efficiency of various antimicrobial dressings. This poses a severe threat to the anti-biofilm market's global expansion.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Region-wise Analysis

Which Region is projected to Offer Significant Opportunity for Anti-biofilm Wound Dressing?

During the projected period, the market in Asia Pacific is expected to grow at the fastest rate. The presence of growing countries such as Japan, India, and China is expected to propel the market expansion. Furthermore, the expanding medical tourism business in these countries is adding to the region's increased demand for wound dressing products.

Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Conect me to identify wining opportunities

Ask An Expert
I'm Available

Country-wise Analysis

U.S. Anti-biofilm Wound Dressing Market Analysis

The U.S. is expected to account for a significant share of the anti-biofilm wound dressing market. Some of the key factors that are projected to drive the market in the country include an increase in the number of sports injuries, a rise in the number of traffic accidents, and the existence of numerous important competitors in the region. Furthermore, the presence of a well-developed healthcare infrastructure as well as advantageous reimbursement policies is likely to drive market expansion during the projection period.

Category-wise Insights

Which Mode of Mechanism is expected to grow the fastest?

Due to the rising frequency of chronic wounds and the increasing number of surgeries globally, the chemical mode of mechanism segment held a significant share of over 40% in 2022 and is expected to increase at a fast pace over the projected period. Chemical-based anti-biofilm wound dressings provide multi-faceted anti-biofilm activity, allowing chronic wounds to heal faster and recover more efficiently.

They also reduce biofilm load on both chronic and acute wounds, as well as the danger of microorganism recontamination. Ionic silver, iodine, EDTA, and other chemicals make up the chemical portion.

What are the Insights about the application of the Anti-biofilm Wound Dressing Market?

Because of the rising incidence of burns and trauma, as well as the increasing number of operations around the world, the acute wounds segment maintained the highest share of over 55% in 2020. Incisions, abrasions, burns, scratches, and puncture wounds are examples of acute lesions to the skin that occur suddenly. It heals normally in accordance with the typical wound-healing procedure.

These wounds can occur anywhere on the body and range in size from little scratches to serious wounds. Surgical or traumatic wounds, as well as burns wounds, are divided under the acute wound category. The severity and location of acute wounds will determine how they are treated. The primary treatment, on the other hand, consists of wound dressing and biofilm prevention. As a result, the market is predicted to develop as the number of people suffering from acute wounds rises.

Competitive Analysis

Partnerships, mergers, and acquisitions are being pursued by companies in order to strengthen their product portfolios, expand their manufacturing facilities, and create competitive difference. Smith & Nephew PLC, for example, announced the acquisition of Osiris Therapeutics, Inc., a regenerative medicine company, in April 2019. The company will expedite the development of its advanced wound management product line as a result of this purchase, thereby expanding its client base and market reach. The company's growth is expected to be boosted as a result of this strategy.

The key participants in the anti-biofilm wound dressing market include ConvaTec, Smith & Nephew PLC, Urgo Medical, Coloplast, 3M, Urgo Medical, Next Science, Monarch Labs, Mega Pharma (Pvt) Ltd., BioMonde, B. Braun Melsungen AG, Molnlycke Healthcare, Lohmann & Rauscher, and Arobella Medical.

Some of the recent developments of key players in the Anti-biofilm Wound Dressing Market are as follows:

  • In August 2022, Imbed Biosciences, a pioneer in innovative biomaterials and soft tissue healing devices, established a partnership with Spartan Medical. Customers at the Department of Veteran Affairs and Department of Defense will have access to both the Microlyte Matrix and Microlyte Surgical product lines through VA IDIQ Contract with the US Federal Government, and Spartan's Medical's Distribution and Pricing Agreement.
  • In January 2020, ConvaTec Group Plc announced the debut of a new product dubbed "ConvaMax". Leg ulcers, pressure ulcers, diabetic foot ulcers, and dehisced surgical wounds are all treated with this new treatment. Furthermore, the product is available in non-adhesive forms, allowing sovereignty in adding compression bands or an additional primary dressing to assist the care regimen.
  • In April 2019, Smith & Nephew plc announced the acquisition of Osiris Therapeutics, Inc for a total equity value of approximately US$ 660 Million. Smith & Nephew's Advanced Wound Management franchise will benefit from the merging of the two companies.

Similarly, recent developments related to companies offering Anti-biofilm Wound Dressing have been tracked by the team at Persistence Market Research, which is available in the full report.

Market Segments Covered in Anti-biofilm Wound Dressing Industry Analysis

By Mode of Mechanism

  • Physical
    • Manual Debridement
    • Pulse Electrical Field
    • Ultrasound Debridement
    • Others
  • Chemical
    • Ionic Silver
    • Iodine
    • EDTA
    • Others
  • Biological
    • Dispersin B
    • Lactoferrin
    • Bacteriophage
    • Others

By Application

  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Others
  • Acute Wounds
    • Surgical & Traumatic Wounds
    • Burn Wounds
    • Others

By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Malaysia
    • Indonesia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Rest of MEA

- Companies Covered in This Report -

  • ConvaTec
  • Smith & Nephew PLC
  • Urgo Medical
  • Coloplast
  • 3M
  • Urgo Medical
  • Next Science
  • Monarch Labs
  • Mega Pharma (Pvt) Ltd.
  • BioMonde
  • B. Braun Melsungen AG
  • Molnlycke Healthcare
  • Lohmann & Rauscher
  • Arobella Medical

- Frequently Asked Questions -

The global Anti-biofilm Wound Dressing market is worth more than US$ 729.7 Million at present.

The market value is projected to increase at a CAGR of around 11.2% from 2023 to 2033.

The market value of Anti-biofilm Wound Dressing increased at a CAGR of around 10% during 2018 – 2022.

Top 5 countries driving demand for Anti-biofilm Wound Dressing are the U.S., China, Japan, Canada and Germany.

North America accounted for over 40% of global Anti-biofilm Wound Dressing demand in 2020.

The UK market for Anti-biofilm Wound Dressing is projected to expand at a CAGR of around 12.5% during 2023 – 2033.

While the market in South Korea is expected to grow at nearly 12%, the market in Japan is projected to register a CAGR of nearly 12.1% during 2023 - 2033.

Google translate